Skip to content

Adverse events associated with glucocorticoid-related intestinal microbiota disturbances in hypertensive patients during pregnancy: prospective controlled study protocol

Adverse events associated with glucocorticoid-related intestinal microbiota disturbances in hypertensive patients during pregnancy: prospective controlled study protocol

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078466
Enrollment
Unknown
Registered
2023-12-08
Start date
2024-01-01
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive disorder complicating pregnancy

Interventions

Control group:NA
gestational hypertension did not use glucocorticoids during pregnancy:NA
gestational hypertension was used glucocorticoids during pregnancy:NA

Sponsors

the Second Affiliated Hospital of Harbin Medical
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Age > 18 years, age at delivery <35 years, single pregnancy, gestational age 12-14 weeks ultrasound indicates normal intrauterine pregnancy.

Exclusion criteria

Exclusion criteria: Diagnosed psychiatric disorders, diagnosed intestinal disorders, illicit drug use, antibiotic use, prebiotic or probiotic supplementation, pregnancy beyond 12 weeks of gestation at time of recruitment, preconception diabetes, hypertension or other serious illness, other comorbiditions such as gestational diabetes, multiple pregnancies, previous bariatric surgery, alcohol or drug abuse.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;pregnancy outcome;

Countries

China

Contacts

Public ContactMan Guo

the Second Affiliated Hospital of Harbin Medical

51864118@qq.com+86 136 5454 4297

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026